Patents by Inventor Kevin Docherty

Kevin Docherty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10865387
    Abstract: The present invention relates to methods of producing pancreatic endocrine cells and uses of the cells obtained using the methods. The method utilises inhibitors or combinations of factors to provide increased quantities of endocrine material, for example for transplantation purposes.
    Type: Grant
    Filed: May 14, 2015
    Date of Patent: December 15, 2020
    Assignee: THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN REGENT WALK
    Inventors: Kevin Docherty, Hilary Margaret Docherty, Maria Joao Marques De Lima, Kenneth Ross Muir, John Joseph Casey
  • Publication number: 20170175081
    Abstract: The present invention provides methods and materials relating to obtaining or expanding populations of islet cells, and uses of the islet cells obtained by these methods, for example in the treatment of diabetes. The invention uses transcription factors in a process of expansion and de-differention, followed by redifferentiation.
    Type: Application
    Filed: May 14, 2015
    Publication date: June 22, 2017
    Inventors: Kevin Docherty, Hilary Margaret Docherty, Maria Joao Marques De Lima, Kenneth Ross Muir, John Joseph Casey
  • Publication number: 20170073642
    Abstract: The present invention relates to methods of producing pancreatic endocrine cells and uses of the cells obtained using the methods. The method utilises inhibitors or combinations of factors to provide increased quantities of endocrine material, for example for transplantation purposes.
    Type: Application
    Filed: May 14, 2015
    Publication date: March 16, 2017
    Inventors: Kevin Docherty, Hilary Margaret Docherty, Maria Joao Marques De Lima, Kenneth Ross Muir, John Joseph Casey
  • Patent number: 6372501
    Abstract: The present invention provides an immortalized insulin producing human &bgr;-cell which may be rendered glucose responsive by suitable bioengineering methods. The invention also provides a method for producing an immortalized glucose responsive insulin producing human &bgr;-cell comprising the steps of selecting an unregulated immortalized human insulin secreting &bgr;-cell, transecting said selected cell line with elements for the genetic control of glucose responsiveness and proliferating said transfected &bgr;-cell accordingly.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: April 16, 2002
    Assignees: Aberdeen University, The University of Sheffield, The University of Leicester, University College London
    Inventors: Albert Aynsley-Green, Keith Lindley, Kevin Docherty, Mark Dunne, Wendy MacFarlane, Roger Frank Lever James